Why insider trading matters?

Numerous studies have examined whether there is evidence that U.S. insiders systematically trade on private information despite the legal deterrence. The consensus appears to be that insider purchases (but not sales) tend to be followed by positive abnormal stock price performance, particularly for small growth stocks.

- Prof. B. Espen Eckbo, Dartmouth College
AVADEL PHARMACEUTICALS PLC (AVDL)
Sector: Healthcare; Industry: Drug Manufacturers—Specialty & Generic

Avadel Pharmaceuticals plc operates as a specialty pharmaceutical company in the United States, France, and Ireland. The company was formerly known as Flamel Technologies SA and changed its name to Avadel Pharmaceuticals PLC in January 2017.


Trade Date Insider Title Buy/Sell #Shares Price Value Option
2020-09-18 MCHUGH THOMAS S Chief Financial Officer Buy 4,000 $6.00 $24,000 No
2020-09-17 McCamish Mark Anthony Director Buy 171,000 $5.76 $985,219 No
2020-09-17 Ende Eric J Director Buy 17,000 $5.79 $98,376 No
2020-08-28 MCHUGH THOMAS S Chief Financial Officer Buy 7,500 $6.77 $50,776 No
2020-08-28 Glass Geoffrey Michael Director Buy 4,800 $6.78 $32,560 No
2020-08-13 MCHUGH THOMAS S Chief Financial Officer Buy 10,000 $7.78 $77,814 No
2020-08-14 Palczuk Linda Director Buy 2,500 $7.94 $19,850 No
2020-08-13 Ende Eric J Director Buy 5,000 $7.79 $38,928 No
2020-08-13 Glass Geoffrey Michael Director Buy 13,000 $7.73 $100,490 No
2020-08-12 Ende Eric J Director Buy 15,000 $7.76 $116,355 No
2020-08-12 Divis Gregory J Chief Executive Officer Buy 13,000 $7.78 $101,156 No
2019-12-12 Hatten Sandra L See Remarks Sell 3,072 $7.23 $22,211 No
2019-12-04 Ende Eric J Director Buy 10,000 $5.97 $59,700 No
2019-12-03 Palczuk Linda Director Buy 7,500 $5.91 $44,325 No
2019-11-18 Glass Geoffrey Michael Director Buy 20,000 $4.99 $99,800 No
2019-11-15 DIVIS GREG J Chief Executive Officer Buy 19,000 $5.13 $97,470 No
2019-11-15 Ende Eric J Director Buy 10,000 $4.98 $49,762 No
2018-12-14 KANAN MICHAEL F See Remarks Sell 8,429 $2.49 $21,022 No
2018-12-14 GUSKY DAVID P Controller & CAO Sell 617 $2.68 $1,656 No
2018-12-14 Hatten Sandra L See Remarks Sell 3,173 $2.58 $8,183 No
2018-08-10 ANDERSON MICHAEL S Chief Executive Officer Sell 16,297 $4.91 $79,953 No
2018-08-10 Hatten Sandra L See Remarks Sell 6,290 $4.91 $30,859 No
2018-06-26 KANAN MICHAEL F See Remarks Buy 1,967 $5.70 $11,212 No
2018-06-26 ANDERSON MICHAEL S Chief Executive Officer Buy 2,500 $6.04 $15,100 No
2018-06-26 DIVIS GREG J See Remarks Buy 16,000 $6.00 $96,000 No
2018-06-26 THOMPSON PHILLANDAS T. See Remarks Buy 10,000 $5.77 $57,700 No
2018-06-25 Flynn James E *Possible member of 10% group Sell 114,034 $5.99 $683,315 No
2018-05-24 ANDERSON MICHAEL S Chief Executive Officer Buy 3,000 $6.44 $19,320 No
2017-12-15 STAPLETON CRAIG R Director Buy 140,000 $8.67 $1,213,940 No
2017-12-07 ANDERSON MICHAEL S Chief Executive Officer Buy 5,000 $8.86 $44,295 No

Insider Smart

Edesa Biotech, Inc. (EDSA) - President and CEO bought shares of EDSA in late May around $3, two weeks after their purchase, the stock jump to $9, very well timed buy.

Insider Smart

Delta Airlines (DAL) - From an insider's perspective: airlines are the first ones to go under due to the pandemic. A lot of concerns were raised on possible bankruptcy especially amid by the dump from Buffett. However, insiders of Delta were bold enough to buy when Buffett was fear. And Delta is the only airline bought by insiders post-Buffett-dump.